Stock NKTR NEKTAR THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Charts Nektar Therapeutics

Equities

NKTR

US6402681083

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.32 USD 0.00% Intraday chart for Nektar Therapeutics +6.45% +133.63%
Apr. 24 Biolojic Design Announces Nektar Therapeutics Exercised Its License Option to Develop an AI-Designed Agonistic Antibody Targeting TNFR2 for the Treatment of Autoimmune Diseases CI
Mar. 19 Nektar Therapeutics announced that it has received $30 million in funding from TCG Crossover Management, LLC CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Neutral

Bullish

Bullish

Resistance 1.670 1.670 1.670
Spread/Res.-20.96%-20.96%-20.96%
Spread/Supp.+38.13%+38.13%+53.45%
Support 0.9556 0.9556 0.8602

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. NKTR Stock
  4. Charts Nektar Therapeutics